Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAge Labs (BIOA) Share-based Compensation (2024 - 2025)

BioAge Labs (BIOA) has disclosed Share-based Compensation for 2 consecutive years, with $2.7 million as the latest value for Q4 2025.

  • Quarterly Share-based Compensation changed 0.04% to $2.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.7 million through Dec 2025, up 67.52% year-over-year, with the annual reading at $11.7 million for FY2025, 67.52% up from the prior year.
  • Share-based Compensation hit $2.7 million in Q4 2025 for BioAge Labs, down from $2.8 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $3.2 million in Q2 2025 to a low of $852000.0 in Q1 2024.